Top Markets
#1 Rain Rain +17.54%
#2 Axie Infinity Axie Infinity +16.67%
#3 Collect on Fanable Collect on Fanable +16.14%
#4 Pharos Pharos +15.32%
#5 Aethir Aethir +14.52%
#6 Beam Beam +13.26%
#7 Ore Ore +13.10%
#8 Basic Attention Basic Attention +11.92%
#9 Phala Phala +11.70%
#10 Espresso Espresso +9.55%
Coin of the day
Rain Rain
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
CYduct Diagnostics, Inc. CYduct Diagnostics, Inc.

CYduct Diagnostics, Inc.

CYDX
Clasificación en acciones #36385
CYduct Diagnostics, Inc. operates as a medical instrument enterprise that... CYduct Diagnostics, Inc. operates as a medical instrument enterprise that engineers and commercializes a diverse range of technologies, equipment, and methodologies. These innovations are purposed for the detection, diagnosis, therapeutic intervention, and general management of various health conditions and illnesses. The company's extensive product offerings include specialized breast endoscopy systems, an assortment of camera solutions (such as 3-chip and 1-chip models), and all necessary accessories. They also provide a broad selection of endoscopic instruments, encompassing surgical tools like dissectors, graspers, scissors, needle holders, fan retractors, cautery devices, and insufflation needles. Furthermore, CYduct supplies illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps, alongside insufflators. For surgical specialties, their portfolio features laparoscopic instruments designed for general surgery, lymphadenectomy, gynecology, and thorascopy. Complementing these are rigid scopes (like laparoscopes, operative scopes, and cystoscopes) with their corresponding accessories, as well as trocar and cannula sets, video carts, and both insulated and non-insulated instrument handles. Uniquely, the company also provides instrumentation tailored for veterinary applications. Established in 1986, CYduct Diagnostics, Inc. is headquartered in Westport, Connecticut. The firm was formerly known as Solos Endoscopy, Inc., before adopting its current name in December 2020.
Precio por acción
$0.5
Última sincronización: 2026-10-01
Capitalización bursátil
$2.62M
Cambio (1 día)
0.00%
Cambio (1 año)
85.19%
País
US
Comercio CYduct Diagnostics, Inc. (CYDX)

Categoría

Healthcare
Ratio P/E de CYduct Diagnostics, Inc. (CYDX)
Ratio P/E al 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de CYduct Diagnostics, Inc., el P/E actual (TTM) de la empresa es 0. Al final de 2026, la empresa tenía un P/E de 0.
Historial del ratio P/E de CYduct Diagnostics, Inc. desde 2026 hasta 2026
Relación P/E al final de cada año
Año Ratio P/E Cambiar
Not enough data for the provided dates.
Relación P/E para empresas similares o competidores
Empresa P/E Ratio Diferencia del P/E Ratio País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 31.78 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 28.32 -
US
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 17.60 -
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE
¿Cómo leer un P/E ratio?

El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.

Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.

Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.